|
ATCC
caption a7 antibiotic b mic Caption A7 Antibiotic B Mic, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/caption a7 antibiotic b mic/product/ATCC Average 99 stars, based on 1 article reviews
caption a7 antibiotic b mic - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
|
NSABP Foundation
immunohistochemistry  Immunohistochemistry, supplied by NSABP Foundation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/immunohistochemistry/product/NSABP Foundation Average 90 stars, based on 1 article reviews
immunohistochemistry - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
NSABP Foundation
ihc immunohistochemistry Ihc Immunohistochemistry, supplied by NSABP Foundation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/ihc immunohistochemistry/product/NSABP Foundation Average 90 stars, based on 1 article reviews
ihc immunohistochemistry - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Amphotericin B is a macrocycle antibiotic first isolated from Streptomyces nodosus. Its antifungal activity is exerted by interacting with the fungal membrane, mainly ergosterol, and inducing pore formation. The increase in membrane permeability causes loss
|
Buy from Supplier |
Image Search Results
Journal: Breast cancer research and treatment
Article Title: Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43
doi: 10.1007/s10549-013-2755-z
Figure Lengend Snippet: CONSORT: NSABP B-43 IHC immunohistochemistry, FISH fluorescence in situ hybridization
Article Snippet: For patients who have hormone receptor-positive DCIS, hormonal therapy should be given for a minimum of 5 years by investigator discretion ( , CONSORT; , Schema). fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a
Techniques: Immunohistochemistry, Fluorescence, In Situ Hybridization
Journal: Breast cancer research and treatment
Article Title: Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43
doi: 10.1007/s10549-013-2755-z
Figure Lengend Snippet: CONSORT: NSABP B-43 IHC immunohistochemistry, FISH fluorescence in situ hybridization
Article Snippet: For patients who have hormone receptor-positive DCIS, hormonal therapy should be given for a minimum of 5 years by investigator discretion ( , CONSORT; , Schema). fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a
Techniques: Immunohistochemistry, Fluorescence, In Situ Hybridization
Journal: Breast cancer research and treatment
Article Title: Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43
doi: 10.1007/s10549-013-2755-z
Figure Lengend Snippet: Schema NSABP B-43
Article Snippet: For patients who have hormone receptor-positive DCIS, hormonal therapy should be given for a minimum of 5 years by investigator discretion ( , CONSORT; , Schema). fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a
Techniques: